MRI-guided STN DBS in Parkinson's disease without microelectrode recording: Efficacy and safety

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 82, Issue 4, 2011, Pages 358-363

  Foltynie, Thomas ^a   Zrinzo, L ^a,b   Martinez Torres, I ^c   Tripoliti, E ^a   Petersen, E ^d   Holl, E ^a,e   Aviles Olmos, I ^a   Jahanshahi, M ^a   Hariz, M ^a,f   Limousin, P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

^f UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN HEMORRHAGE; CLINICAL TRIAL; DISABILITY; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG USE; DYSKINESIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROELECTRODE RECORDING; MOTOR PERFORMANCE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PAIN; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; RECORDING; STEREOTACTIC TREATMENT; SUBTHALAMIC NUCLEUS BRAIN DEPTH STIMULATION; TREATMENT RESPONSE; UNIFIED PARKINSON DISEASE RATING SCALE;

ADULT; AGED; DEEP BRAIN STIMULATION; ELECTRODES, IMPLANTED; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICROELECTRODES; MIDDLE AGED; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; SUBTHALAMIC NUCLEUS;

EID: 79952717639     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2010.205542     Document Type: Article

References (29)

1. Leksell L, Leksell D, Schwebel J. Stereotaxis and nuclear magnetic resonance. J Neurol Neurosurg Psychiatry 1985;48:14-18. (Pubitemid 15080585)
2. Limousin P, Pollak P, Benazzouz A, et al. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995;345:91-5.
3. Krack P, Batir A, van Blercom N, et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003;349:1925-34.
4. Hariz MI, Rehncrona S, Quinn NP, et al. Multicenter study on deep brain stimulation in Parkinson's disease: an independent assessment of reported adverse events at 4 years. Mov Disord 2008;23:416-21.
5. Tripoliti E, Zrinzo L, Martinez-Torres I, et al. Effects of contact location and voltage amplitude on speech and movement in bilateral subthalamic nucleus deep brain stimulation. Mov Disord 2008;23:2377-83.
6. Patel NK, Plaha P, Gill SS. Magnetic resonance imaging-directed method for functional neurosurgery using implantable guide tubes. Neurosurgery 2007;61:358-65.
7. Williams-Gray CH, Foltynie T, Brayne CE, et al. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 2007;130:1787-98.
8. Yorkston KM, Beukelman DR, Traynor CD. Articulatory adequacy in dysarthric speakers: a comparison of judging formats. J Commun Disord 1988;21:351-61.
9. Jenkinson C, Fitzpatrick R, Peto V, et al. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing 1997;26:353-7. (Pubitemid 27448379)
10. Ashkan K, Blomstedt P, Zrinzo L, et al. Variability of the subthalamic nucleus: the case for direct MRI guided targeting. Br J Neurosurg 2007;21:197-200. (Pubitemid 46572892)
11. Hariz MI, Krack P, Melvill R, et al. A quick and universal method for stereotactic visualization of the subthalamic nucleus before and after implantation of deep brain stimulation electrodes. Stereotact Funct Neurosurg 2003;80:96-101. (Pubitemid 38182751)
12. Elias WJ, Sansur CA, Frysinger RC. Sulcal and ventricular trajectories in stereotactic surgery. J Neurosurg 2009;110:201-7.
13. Zrinzo L, van Hulzen AL, Gorgulho AA, et al. Avoiding the ventricle: a simple step to improve accuracy of anatomical targeting during deep brain stimulation. J Neurosurg 2009;110:1283-90.
14. Bejjani BP, Dormont D, Pidoux B, et al. Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg 2000;92:615-25. (Pubitemid 30180666)
15. Yelnik J, Bardinet E, Dormont D, et al. A three-dimensional, histological and deformable atlas of the human basal ganglia. I. Atlas construction based on immunohistochemical and MRI data. Neuroimage 2007;34:618-38.
16. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006;355:896-908. (Pubitemid 44315982)
17. Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009;301:63-73.
18. Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006;21: S290-304.
19. Weaver F, Follett K, Hur K, et al. Deep brain stimulation in Parkinson disease: a meta analysis of patient outcomes. J Neurosurg 2005;103:956-67. (Pubitemid 43194543)
20. Hariz MI. Safety and risk of microelectrode recording in surgery for movement disorders. Stereotact Funct Neurosurg 2002;78:146-57. (Pubitemid 36351215)
21. Alkhani A, Lozano AM. Pallidotomy for parkinson disease: a review of contemporary literature. J Neurosurg 2001;94:43-9. (Pubitemid 32799470)
22. Hariz MI, Fodstad H. Do microelectrode techniques increase accuracy or decrease risks in pallidotomy and deep brain stimulation? A critical review of the literature. Stereotact Funct Neurosurg 1999;72:157-69. (Pubitemid 30237262)
23. Binder DK, Rau GM, Starr PA. Risk factors for hemorrhage during microelectrode-guided deep brain stimulator implantation for movement disorders. Neurosurgery 2005;56:722-32.
24. Ben-Haim S, Asaad WF, Gale JT, et al. Risk factors for hemorrhage during microelectrode-guided deep brain stimulation and the introduction of an improved microelectrode design. Neurosurgery 2009;64:754-62.
25. Goodman RR, Kim B, McClelland S III, et al. Operative techniques and morbidity with subthalamic nucleus deep brain stimulation in 100 consecutive patients with advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 2006;77:12-17. (Pubitemid 43022683)
26. Ory-Magne F, Brefel-Courbon C, Simonetta-Moreau M, et al. Does ageing influence deep brain stimulation outcomes in Parkinson's disease? Mov Disord 2007;22:1457-63.
27. Sansur CA, Frysinger RC, Pouratian N, et al. Incidence of symptomatic hemorrhage after stereotactic electrode placement. J Neurosurg 2007;107:998-1003. (Pubitemid 350255215)
28. Hamani C, Richter E, Schwalb JM, et al. Bilateral subthalamic nucleus stimulation for Parkinson's disease: a systematic review of the clinical literature. Neurosurgery 2005;56:1313-21. (Pubitemid 40770456)
29. Deep Brain Stimulation Study Group. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001;345:956-63.